Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
复制标题
DOI:
10.1016/j.jacc.2017.09.028
复制
发表时间:
2017-10-31
影响因子:
24
通讯作者:
Libby P
中科院分区:
文献类型:
--
作者:
Libby P
Inflammatory pathways drive atherogenesis and link traditional risk factors to atherosclerosis and its complications. One inflammatory mediator has come to the fore as a therapeutic target in cardiovascular disease. The experimental and clinical evidence reviewed here support interleukin-1 beta (IL-1β) as both a local vascular and systemic contributor in this regard. Intrinsic vascular wall cells and lesional leukocytes alike can produce this cytokine. Local stimuli in the plaque favor the generation of active IL-1β through the action of a molecular assembly known as the inflammasome. Clinically applicable interventions that interfere with IL-1 action can improve cardiovascular outcomes, ushering in a new era of anti-inflammatory therapies for atherosclerosis. The translational path described here illustrates how advances in basic vascular biology may transform therapy. Biomarker-directed application of anti-inflammatory interventions promises to help us achieve a more precise and personalized allocation of therapy for our cardiovascular patients.
登录
查看更多内容
影响因子:
37.8
作者:
Cook NR;Paynter NP;Eaton CB;Manson JE;Martin LW;Robinson JG;Rossouw JE;Wassertheil-Smoller S;Ridker PM
通讯作者:
Ridker PM
影响因子:
20.1
作者:
GALIS, ZS;MUSZYNSKI, M;LIBBY, P
通讯作者:
LIBBY, P
影响因子:
6.8
作者:
Abbate, Antonio;Van Tassell, Benjamin W.;Biondi-Zoccai, Giuseppe G. L.
通讯作者:
Biondi-Zoccai, Giuseppe G. L.
影响因子:
9.2
作者:
Dinarello, Charles A.
通讯作者:
Dinarello, Charles A.
影响因子:
15.9
作者:
Alexander, Matthew R.;Moehle, Christopher W.;Owens, Gary K.
通讯作者:
Owens, Gary K.